These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 2177633)
1. Identification of a serum-inducible messenger RNA (5B10) as the mouse homologue of calcyclin: tissue distribution and expression in metastatic, ras-transformed NIH 3T3 cells. Guo XJ; Chambers AF; Parfett CL; Waterhouse P; Murphy LC; Reid RE; Craig AM; Edwards DR; Denhardt DT Cell Growth Differ; 1990 Jul; 1(7):333-8. PubMed ID: 2177633 [TBL] [Abstract][Full Text] [Related]
2. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels. Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL Cancer Res; 1996 Dec; 56(23):5391-6. PubMed ID: 8968091 [TBL] [Abstract][Full Text] [Related]
3. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells. Su ZZ; Austin VN; Zimmer SG; Fisher PB Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744 [TBL] [Abstract][Full Text] [Related]
4. Identification of a novel serine protease-like gene, the expression of which is down-regulated during breast cancer progression. Liu XL; Wazer DE; Watanabe K; Band V Cancer Res; 1996 Jul; 56(14):3371-9. PubMed ID: 8764136 [TBL] [Abstract][Full Text] [Related]
5. Isolation of a gene sequence induced later by tumor-promoting 12-O-tetradecanoylphorbol-13-acetate in mouse osteoblastic cells (MC3T3-E1) and expressed constitutively in ras-transformed cells. Nose K; Saito H; Kuroki T Cell Growth Differ; 1990 Nov; 1(11):511-8. PubMed ID: 2088477 [TBL] [Abstract][Full Text] [Related]
6. Antisense DNA inhibition of tumor growth induced by c-Ha-ras oncogene in nude mice. Gray GD; Hernandez OM; Hebel D; Root M; Pow-Sang JM; Wickstrom E Cancer Res; 1993 Feb; 53(3):577-80. PubMed ID: 8425190 [TBL] [Abstract][Full Text] [Related]
7. Regulated temporal and spatial expression of the calcium-binding proteins calcyclin and OPN (osteopontin) in mouse tissues during pregnancy. Waterhouse P; Parhar RS; Guo X; Lala PK; Denhardt DT Mol Reprod Dev; 1992 Aug; 32(4):315-23. PubMed ID: 1497879 [TBL] [Abstract][Full Text] [Related]
8. Human smooth muscle myosin light chain-2 gene expression is repressed in ras transformed fibroblast cells. Kumar CC; Chang C Cell Growth Differ; 1992 Jan; 3(1):1-10. PubMed ID: 1599878 [TBL] [Abstract][Full Text] [Related]
9. Detection of transforming ras proteins containing leucine at position 61 by a new mouse monoclonal antibody, ras(53-69)Leu61. Bizub D; Fischberg-Bender E; Heimer EP; Felix A; Skalka AM Cancer Res; 1989 Nov; 49(22):6425-31. PubMed ID: 2680065 [TBL] [Abstract][Full Text] [Related]
10. ras-transformed NIH 3T3 cell lines, selected for metastatic ability in chick embryos, have increased proportions of p21-expressing cells and are metastatic in nude mice. Chambers AF; Denhardt GH; Wilson SM Invasion Metastasis; 1990; 10(4):225-40. PubMed ID: 2192993 [TBL] [Abstract][Full Text] [Related]
11. The product of the cph oncogene is a truncated, nucleotide-binding protein that enhances cellular survival to stress. Velasco JA; Avila MA; Notario V Oncogene; 1999 Jan; 18(3):689-701. PubMed ID: 9989819 [TBL] [Abstract][Full Text] [Related]
12. Expression of calcyclin in human melanoma cell lines correlates with metastatic behavior in nude mice. Weterman MA; Stoopen GM; van Muijen GN; Kuznicki J; Ruiter DJ; Bloemers HP Cancer Res; 1992 Mar; 52(5):1291-6. PubMed ID: 1737392 [TBL] [Abstract][Full Text] [Related]
13. Gene expression profiling by DNA microarray analysis in mouse embryonic fibroblasts transformed by rasV12 mutated protein and the E1A oncogene. Vasseur S; Malicet C; Calvo EL; Labrie C; Berthezene P; Dagorn JC; Iovanna JL Mol Cancer; 2003 Mar; 2():19. PubMed ID: 12685932 [TBL] [Abstract][Full Text] [Related]
14. Reduced malignancy of ras-transformed NIH 3T3 cells expressing antisense osteopontin RNA. Behrend EI; Craig AM; Wilson SM; Denhardt DT; Chambers AF Cancer Res; 1994 Feb; 54(3):832-7. PubMed ID: 8306346 [TBL] [Abstract][Full Text] [Related]
15. Thy-1 as a negative growth regulator in ras-transformed mouse fibroblasts. Sugimoto Y; Ikawa Y; Nakauchi H Cancer Res; 1991 Jan; 51(1):99-104. PubMed ID: 1670996 [TBL] [Abstract][Full Text] [Related]
16. Molecular cloning of TPAR1, a gene whose expression is repressed by the tumor promoter 12-O-tetradecanoylphorbol 13-acetate (TPA). Jiang W; Zhou P; Kahn SM; Tomita N; Johnson MD; Weinstein IB Exp Cell Res; 1994 Dec; 215(2):284-93. PubMed ID: 7982471 [TBL] [Abstract][Full Text] [Related]
17. Expression and phenotypic alterations caused by an inducible transforming ras oncogene introduced into rat liver epithelial cells. Huber BE; Cordingley MG Oncogene; 1988 Sep; 3(3):245-56. PubMed ID: 3060790 [TBL] [Abstract][Full Text] [Related]
18. Fibroblasts transformed by different ras oncogenes show dissimilar patterns of protease gene expression and regulation. Zhang JY; Schultz RM Cancer Res; 1992 Dec; 52(23):6682-9. PubMed ID: 1423314 [TBL] [Abstract][Full Text] [Related]
20. Cell and tissue-type specific expression of Ras-related GTPase RhoB. Fritz G; Gnad R; Kaina B Anticancer Res; 1999; 19(3A):1681-8. PubMed ID: 10470101 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]